News | June 14, 2026
Suven Life Sciences to showcase narcolepsy program Samelisant at SLEEP 2026
Samelisant will be the centerpiece of Suven’s scientific presence
Samelisant will be the centerpiece of Suven’s scientific presence
Cervical cancer remains one of the leading causes of cancer deaths among women in India
Partnership will provide funding, incubation, mentorship, and industry exposure for ventures in healthcare, pharmaceuticals, biotechnology, medical technology, and agriculture
Molbio Diagnostics' Truenat HPV-HR Plus becomes the world's first formally validated reduced-valency HPV test, meeting WHO-IARC standards
Approval is based on results from the phase 3 OASIS 4 clinical trial
Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion
The union minister spoke at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi
SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
Company experts to participate in eight sessions covering AI-powered clinical development, regulatory innovation, oncology research, and patient engagement
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
